BioSpace News Archive

ALSAC and LeMoyne-Owen College have together launched the LeMoyne-Owen College University Engagement Call Center, a St. Jude donor engagement facility, on the LeMoyne-Owen College campus.

ViTel Net announces Mark Noble, MBA, as Senior Vice President of Business Development.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company’s New Drug Application (NDA) seeking marketing approval for solriamfetol, an investigational medicine for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA).

Tricida, Inc. announced today that it has entered into a $100 million venture debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets.

Perlara, a drug discovery platform company partnering with highly motivated families and drug developers to treat diseases thought too rare to attract the interest of pharmaceutical companies, today announced a collaboration with Harvard Medical School and the Undiagnosed Diseases Network to launch PerlQuests for two rare monogenic neurodevelopmental disorders.

Lexmark booth to feature devices and solutions that streamline paper-based processes in healthcare.

The award was created to encourage original research in the areas of human milk science and breastfeeding medicine, and to support the advancement of emerging researchers in this vital area of science.

Governor Rick Snyder signed critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.

AmorChem selected these highly qualified individuals because collectively, they offer an enviable array of diversified expertise and experience in lifesciences venture capital investment, drug discovery and pharmaceutical development.

The Compensation Committee of the Company’s Board of Directors has approved the grant effective on February 28, 2018 of inducement stock options to purchase 200,000 shares of common stock to Heather D. Turner, J.D., Senior Vice President and General Counsel.